PURPOSE: To use noninvasive fluorescence imaging to investigate the influence of molecular weight (MW) of proteins on the rate of loss from a subcutaneous (SC) injection site and subsequent uptake by the draining lymph nodes in mice. METHODS: Bevacizumab (149 kDa), bovine serum albumin (BSA, 66 kDa), ovalbumin (44.3 kDa) or VEGF-C156S (23 kDa), labeled with the near infrared dye IRDye 680, were injected SC into the front footpad of SKH-1 mice. Whole body non-invasive fluorescence imaging was performed to quantitate the fluorescence signal at the injection site and in axillary lymph nodes. RESULTS: The half-life values, describing the times for 50% loss of proteins from the injection site, were 6.81 h for bevacizumab, 2.85 h for BSA, 1.57 h for ovalbumin and 0.31 h for VEGF-C156S. The corresponding axillary lymph node exposure, represented as the area of the % dose versus time curve, was 6.27, 5.13, 4.06 and 1.54% dose ∙ h, respectively. CONCLUSIONS: Our results indicate that the rate of loss of proteins from a SC injection site is inversely related to MW of proteins, while lymph node exposure is proportionally related to the MW of proteins in a mouse model.
PURPOSE: To use noninvasive fluorescence imaging to investigate the influence of molecular weight (MW) of proteins on the rate of loss from a subcutaneous (SC) injection site and subsequent uptake by the draining lymph nodes in mice. METHODS:Bevacizumab (149 kDa), bovineserum albumin (BSA, 66 kDa), ovalbumin (44.3 kDa) or VEGF-C156S (23 kDa), labeled with the near infrared dye IRDye 680, were injected SC into the front footpad of SKH-1 mice. Whole body non-invasive fluorescence imaging was performed to quantitate the fluorescence signal at the injection site and in axillary lymph nodes. RESULTS: The half-life values, describing the times for 50% loss of proteins from the injection site, were 6.81 h for bevacizumab, 2.85 h for BSA, 1.57 h for ovalbumin and 0.31 h for VEGF-C156S. The corresponding axillary lymph node exposure, represented as the area of the % dose versus time curve, was 6.27, 5.13, 4.06 and 1.54% dose ∙ h, respectively. CONCLUSIONS: Our results indicate that the rate of loss of proteins from a SC injection site is inversely related to MW of proteins, while lymph node exposure is proportionally related to the MW of proteins in a mouse model.
Authors: Byung Soo Kim; Jae Min Oh; Hoon Hyun; Kyung Sook Kim; Sang Hyo Lee; Yu Han Kim; Kinam Park; Hai Bang Lee; Moon Suk Kim Journal: Mol Pharm Date: 2009 Mar-Apr Impact factor: 4.939
Authors: Manolo D Plasencia; Dragan Isailovic; Samuel I Merenbloom; Yehia Mechref; Milos V Novotny; David E Clemmer Journal: J Am Soc Mass Spectrom Date: 2008-07-31 Impact factor: 3.109
Authors: Colin R Zamecnik; Margaret M Lowe; David M Patterson; Michael D Rosenblum; Tejal A Desai Journal: ACS Nano Date: 2017-11-15 Impact factor: 15.881
Authors: Kenneth M Tichauer; Kimberley S Samkoe; Jason R Gunn; Stephen C Kanick; P Jack Hoopes; Richard J Barth; Peter A Kaufman; Tayyaba Hasan; Brian W Pogue Journal: Nat Med Date: 2014-10-26 Impact factor: 53.440